FilingReader Intelligence
Sunflower Pharmaceutical invests 20m yuan in new subsidiaries
July 25, 2025 at 05:20 PM UTC•By FilingReader AI
Sunflower Pharmaceutical Group will invest 20 million yuan to establish two new wholly-owned subsidiaries with 10 million yuan capital each.
The company is simultaneously deregistering one subsidiary and absorbing two others into its main pharmaceutical unit to consolidate resources and optimize its holding structure.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002737•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Sunflower Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime